TMQ

Trilogy is a base-metals exploration company with zero mining revenue in any year on record; its sole asset is a 50/50 JV (Ambler Metals) with South32 over undeveloped copper-zinc projects in a roadless part of Alaska. The FY2025 net loss ballooned to -$42.2M (from -$8.59M in FY2024, a -391.9% swing), driving ROE to -34.0% and pushing accumulated deficit to -$133M. With no revenue line to grow into, every dollar of spend is a dollar of shareholder capital consumed, and operating cash flow was negative (-$3.25M). This is not a business you value on earnings — it is a call option on a permitting-and-financing outcome that management itself flags as uncertain.

The balance sheet is superficially clean — $51.6M cash (up 99.8%), $124M equity, and a low 0.27x liabilities/equity — but that cash was bought with dilution, not operations. The MD&A discloses the October 2025 ATM sale of 3.5M shares at $7.12 for $24.3M net, plus a live $50M base-shelf and automatic S-3 that pre-authorize continued issuance. Shares already grew 5.2% YoY, and the funding model the company describes (ATM, equity/debt offerings, asset sales, more JVs) is inherently dilutive. Current liabilities spiking to $33.1M (+4,075.7%) alongside the loss is a further tell that the cash cushion is finite against escalating project costs.